Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 13  •  12:57PM ET
344.50
Dollar change
+8.46
Percentage change
2.52
%
IndexS&P 500 P/E13.72 EPS (ttm)25.11 Insider Own0.29% Shs Outstand220.72M Perf Week1.63%
Market Cap76.03B Forward P/E11.68 EPS next Y29.49 Insider Trans0.19% Shs Float220.06M Perf Month-7.60%
Enterprise Value- PEG2.28 EPS next Q10.58 Inst Own91.73% Short Float1.63% Perf Quarter5.15%
Income5.66B P/S0.38 EPS this Y-14.13% Inst Trans-2.17% Short Ratio2.19 Perf Half Y16.61%
Sales199.12B P/B1.73 EPS next Y13.38% ROA4.75% Short Interest3.60M Perf YTD-1.73%
Book/sh198.81 P/C- EPS next 5Y5.12% ROE13.29% 52W High458.75 -24.91% Perf Year-12.03%
Cash/sh- P/FCF23.95 EPS past 3/5Y1.27% 6.99% ROIC7.53% 52W Low273.71 25.86% Perf 3Y-30.43%
Dividend Est.7.11 (2.06%) EV/EBITDA- Sales past 3/5Y8.34% 10.32% Gross Margin- Volatility3.64% 3.65% Perf 5Y18.51%
Dividend TTM6.84 (1.99%) EV/Sales- EPS Y/Y TTM-2.29% Oper. Margin4.07% ATR (14)12.33 Perf 10Y183.42%
Dividend Ex-DateMar 10, 2026 Quick Ratio- Sales Y/Y TTM12.62% Profit Margin2.84% RSI (14)49.34 Recom2.00
Dividend Gr. 3/5Y10.14% 12.47% Current Ratio1.54 EPS Q/Q36.35% SMA20-0.80% Beta0.51 Target Price382.70
Payout27.13% Debt/Eq0.75 Sales Q/Q9.47% SMA50-1.78% Rel Volume0.56 Prev Close336.04
Employees97100 LT Debt/Eq0.71 EarningsJan 28 BMO SMA2000.52% Avg Volume1.64M Price344.50
IPOOct 30, 2001 Option/ShortYes / Yes EPS/Sales Surpr.7.54% -1.07% Trades Volume505,392 Change2.52%
Date Action Analyst Rating Change Price Target Change
Feb-03-26Downgrade RBC Capital Mkts Outperform → Sector Perform $358
Jan-08-26Upgrade Wolfe Research Peer Perform → Outperform $425
Dec-19-25Downgrade Deutsche Bank Buy → Hold $320
Oct-14-25Initiated Goldman Neutral
Jul-21-25Downgrade Argus Buy → Hold
Jul-18-25Downgrade Leerink Partners Outperform → Market Perform $310
Apr-15-25Downgrade Robert W. Baird Outperform → Neutral $529
Mar-17-25Upgrade Argus Hold → Buy $450
Jan-22-25Downgrade Stephens Overweight → Equal-Weight $520 → $440
Oct-18-24Downgrade Argus Buy → Hold
Feb-11-26 11:02PM
09:47AM
07:04AM
Feb-10-26 05:15PM
12:31PM
08:00AM Loading…
08:00AM
Feb-09-26 02:08PM
Feb-06-26 01:32PM
01:23PM
11:31AM
10:41AM
09:50AM
Feb-04-26 06:46AM
12:38AM
Feb-03-26 12:36PM
09:34AM Loading…
09:34AM
03:08AM
Feb-02-26 11:18AM
10:47AM
Jan-31-26 07:48AM
Jan-29-26 02:44PM
09:13AM
02:19AM
12:37AM
Jan-28-26 04:32PM
04:02PM
01:35PM
01:01PM
12:35PM
12:21PM
11:15AM Loading…
11:15AM
10:20AM
10:09AM
10:06AM
09:30AM
07:42AM
07:10AM
06:41AM
06:26AM
06:17AM
06:00AM
Jan-27-26 05:33PM
05:12PM
04:54PM
04:44PM
04:44PM
04:38PM
04:34PM
04:17PM
04:13PM
03:27PM
12:55PM
12:44PM
11:55AM
11:42AM
11:41AM
11:15AM
10:35AM
10:07AM
09:55AM
07:17AM
07:16AM
12:09AM
12:09AM
Jan-26-26 10:19PM
10:09PM
08:20AM
Jan-25-26 12:39PM
07:52AM
Jan-24-26 09:00AM
Jan-23-26 05:25PM
04:42PM
09:15AM
Jan-22-26 12:27PM
06:58AM
Jan-21-26 11:21AM
10:00AM
08:30AM
Jan-20-26 11:05PM
Jan-19-26 09:33AM
07:38AM
Jan-16-26 10:47AM
Jan-15-26 12:14PM
12:04PM
08:00AM
Jan-14-26 12:53PM
Jan-13-26 08:49AM
Jan-12-26 11:33PM
Jan-11-26 11:03AM
Jan-08-26 01:13PM
11:35AM
07:55AM
Jan-06-26 11:04AM
Jan-05-26 11:08AM
09:11AM
Dec-30-25 12:15PM
Dec-29-25 11:59PM
Dec-26-25 11:26AM
Dec-23-25 08:37AM
Dec-22-25 04:30PM
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a comprehensive suite of health plans and services to different customers. The CarelonRx segment markets and offers pharmacy services to affiliated health plan customers, as well as to external customers. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services with the aim of delivering whole health affordably by offering a broad array of healthcare related services. The Corporate & Other segment includes businesses that do not individually meet the quantitative threshold for an operating segment. The company was founded in 1944 and is headquartered in Indianapolis, IN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DeVore Susan D.DirectorAug 19 '25Buy312.151,200374,5803,502Aug 21 04:20 PM
BOUDREAUX GAILPresident and CEOJul 18 '25Buy286.948,5002,438,951151,020Jul 18 01:42 PM
Kaye MarkEVP & CFOApr 24 '25Sale424.824,5881,949,07418,977Apr 25 04:17 PM
Kaye MarkOfficerApr 24 '25Proposed Sale424.814,5881,949,051Apr 24 05:10 PM
Penczek Ronald WCAO & ControllerMar 10 '25Sale415.13443183,9031,847Mar 11 04:20 PM
Penczek Ronald WOfficerMar 10 '25Proposed Sale415.13443183,904Mar 10 02:55 PM
Kendrick Charles Morgan JREVP & President, CommercialMar 05 '25Sale396.303,5041,388,63510,116Mar 05 05:52 PM
Kendrick Charles Morgan JROfficerMar 05 '25Proposed Sale396.303,5041,388,651Mar 05 05:19 PM
Last Close
Feb 13  •  12:57PM ET
71.90
Dollar change
+1.08
Percentage change
1.52
%
UNM Unum Group daily Stock Chart
Index- P/E16.92 EPS (ttm)4.25 Insider Own1.00% Shs Outstand165.69M Perf Week-3.57%
Market Cap12.03B Forward P/E7.25 EPS next Y9.92 Insider Trans-0.74% Shs Float165.66M Perf Month-9.92%
Enterprise Value- PEG0.70 EPS next Q2.12 Inst Own86.99% Short Float1.78% Perf Quarter-7.03%
Income738.50M P/S0.93 EPS this Y9.38% Inst Trans-0.40% Short Ratio2.05 Perf Half Y1.42%
Sales12.98B P/B1.17 EPS next Y11.56% ROA1.40% Short Interest2.94M Perf YTD-7.23%
Book/sh61.49 P/C- EPS next 5Y10.32% ROE6.98% 52W High84.48 -14.89% Perf Year-4.69%
Cash/sh- P/FCF17.46 EPS past 3/5Y-15.03% 1.87% ROIC5.29% 52W Low66.81 7.62% Perf 3Y68.15%
Dividend Est.1.93 (2.68%) EV/EBITDA- Sales past 3/5Y2.16% -0.62% Gross Margin- Volatility4.37% 2.59% Perf 5Y190.62%
Dividend TTM1.80 (2.50%) EV/Sales- EPS Y/Y TTM-55.13% Oper. Margin8.34% ATR (14)2.02 Perf 10Y186.00%
Dividend Ex-DateJan 30, 2026 Quick Ratio- Sales Y/Y TTM0.61% Profit Margin5.69% RSI (14)33.16 Recom1.73
Dividend Gr. 3/5Y11.78% 9.07% Current Ratio- EPS Q/Q-46.03% SMA20-4.13% Beta0.20 Target Price94.23
Payout41.21% Debt/Eq0.37 Sales Q/Q-2.19% SMA50-6.05% Rel Volume0.64 Prev Close70.82
Employees11063 LT Debt/Eq0.37 EarningsFeb 05 AMC SMA200-6.27% Avg Volume1.43M Price71.90
IPONov 06, 1986 Option/ShortYes / Yes EPS/Sales Surpr.-9.10% -1.29% Trades Volume505,570 Change1.52%
Date Action Analyst Rating Change Price Target Change
Sep-16-25Initiated Wolfe Research Outperform $91
Mar-05-25Upgrade Raymond James Mkt Perform → Strong Buy $108
Jan-23-25Initiated BMO Capital Markets Outperform $91
Jan-07-25Downgrade JP Morgan Overweight → Neutral $74 → $79
Nov-14-24Upgrade Evercore ISI In-line → Outperform $67 → $84
Sep-05-24Initiated Barclays Overweight $73
Jul-11-24Initiated Piper Sandler Overweight $57
Jan-03-24Upgrade JP Morgan Neutral → Overweight $55
Apr-25-23Initiated Wells Fargo Overweight $57
Mar-20-23Upgrade Jefferies Hold → Buy $44 → $50
Feb-12-26 12:41AM
Feb-10-26 01:32AM
Feb-07-26 02:07AM
Feb-06-26 02:01PM
11:16AM
10:00AM Loading…
10:00AM
Feb-05-26 08:30PM
06:00PM
05:06PM
04:54PM
04:15PM
Feb-04-26 09:15AM
Feb-03-26 10:16PM
12:06PM
Jan-29-26 10:00AM
12:00PM Loading…
Jan-28-26 12:00PM
Jan-16-26 09:40AM
Jan-15-26 10:00AM
02:50AM
Jan-12-26 12:30PM
Jan-06-26 11:07PM
Dec-21-25 10:31PM
Dec-16-25 11:13AM
Dec-15-25 10:27AM
Dec-11-25 11:33PM
Dec-09-25 12:36PM
Dec-04-25 04:15PM
Dec-03-25 11:30AM
09:39AM
Dec-02-25 12:36PM
04:15PM Loading…
Nov-14-25 04:15PM
Nov-13-25 09:20AM
Nov-11-25 12:32PM
Nov-10-25 12:31AM
Nov-05-25 09:50AM
09:43AM
Nov-04-25 04:06PM
04:02PM
09:35AM
04:40AM
Nov-03-25 08:00PM
06:15PM
05:13PM
04:42PM
04:15PM
11:24AM
Nov-01-25 11:10PM
Oct-29-25 12:43PM
Oct-28-25 10:00AM
Oct-27-25 10:00AM
Oct-22-25 12:36AM
Oct-09-25 10:00AM
Oct-06-25 03:00PM
Sep-30-25 10:30AM
Sep-26-25 01:27PM
Sep-25-25 11:31PM
Sep-24-25 04:37PM
Sep-18-25 12:34PM
Sep-16-25 12:03AM
Sep-03-25 12:35PM
Aug-28-25 11:30AM
11:00AM
12:36AM
Aug-27-25 12:50PM
Aug-20-25 11:53PM
Aug-19-25 10:58AM
Aug-15-25 10:00AM
Aug-13-25 12:18AM
12:02AM
Aug-11-25 08:44PM
09:00AM
Jul-31-25 01:00PM
09:32AM
Jul-30-25 07:55PM
01:40PM
12:55PM
Jul-29-25 08:00PM
06:00PM
05:30PM
04:28PM
04:15PM
Jul-27-25 11:12PM
Jul-24-25 10:58AM
Jul-23-25 05:30PM
10:00AM
Jul-22-25 10:00AM
Jul-21-25 12:07PM
Jul-14-25 12:38PM
Jul-10-25 10:00AM
Jul-09-25 12:06AM
Jul-08-25 10:00AM
Jul-03-25 11:30AM
Jul-02-25 06:24AM
Jul-01-25 11:30PM
04:09PM
04:06PM
Jun-26-25 08:38AM
Jun-16-25 08:14AM
Jun-13-25 01:33PM
09:53AM
Unum Group engages in the provision of financial protection benefits. Its services include disability, life, accident, critical illness, dental, vision, and other related services. It operates through the following segments: Unum US, Unum International, Colonial Life, Closed Block, and Corporate. The Unum US segment focuses on group disability, group life and accidental death and dismemberment products, and supplemental and voluntary lines of business. The Unum International segment engages in the operations of the UK business, which includes insurance for group long-term disability, group life, and supplemental lines of business that include dental, individual disability, and critical illness products. The Colonial Life segment includes insurance for accident, sickness, disability products, life products, and cancer and critical illness products. The Closed Block segment consists of individual disability, group and individual long-term care, and other insurance products no longer actively marketed. The Corporate segment refers to investment income on corporate assets and other corporate income and expenses not allocated to a line of business. The company was founded in 1848 and is headquartered in Chattanooga, TN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rice Walter Lynn JRSVP, Chief Accounting OfficerDec 09 '25Sale73.5090066,1528,940Dec 11 06:44 PM
Rice Walter Lynn JROfficerDec 09 '25Proposed Sale73.5090066,152Dec 09 02:25 PM
Zabel Steven AndrewEVP, Chief Financial OfficerNov 19 '25Sale76.387,500572,865113,807Nov 21 05:13 PM
Zabel Steven AndrewOfficerNov 19 '25Proposed Sale76.387,500572,865Nov 19 03:24 PM
Pyne Christopher WEVP, Group BenefitsNov 07 '25Sale78.044,000312,14851,372Nov 10 06:22 PM
Pyne Christopher WOfficerNov 07 '25Proposed Sale78.044,000312,148Nov 07 03:55 PM
LARSON GLORIA CDirectorJul 02 '25Proposed Sale81.1624,1911,963,239Jul 02 04:16 PM
LARSON GLORIA CDirectorJul 01 '25Proposed Sale81.7640,4003,303,018Jul 01 05:03 PM
LARSON GLORIA CDirectorJun 30 '25Proposed Sale80.4115,0001,206,137Jun 30 01:19 PM
LARSON GLORIA CFormer DirectorJun 27 '25Proposed Sale80.6210,000806,249Jun 27 12:38 PM
Ahmed Elizabeth ClaireEVP, People & CommunicationsMay 07 '25Sale80.0010,000800,00051,170May 12 07:54 AM
Ahmed Elizabeth ClaireOfficerMay 07 '25Proposed Sale80.0010,000800,000May 07 10:08 AM
DeVore Susan D.DirectorMar 03 '25Sale80.8810,000808,78827,396Mar 04 06:03 PM
McKenney Richard PPresident and CEOMar 03 '25Sale81.9950,0004,099,454980,637Mar 04 05:50 PM
IGLESIAS LISA GEVP, General CounselMar 03 '25Sale82.757,000579,25031,284Mar 04 05:45 PM
McKenney Richard POfficerMar 03 '25Proposed Sale81.9950,0004,099,454Mar 03 04:31 PM
DeVore Susan D.DirectorMar 03 '25Proposed Sale80.8810,000808,787Mar 03 04:12 PM
IGLESIAS LISA GOfficerMar 03 '25Proposed Sale82.757,000579,250Mar 03 03:17 PM